AZN

AZN

USD

AstraZeneca PLC American Depositary Shares

$82.030+1.380 (1.711%)

Preço em tempo real

Healthcare
Drug Manufacturers - General
Reino Unido

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$80.650

Máximo

$82.110

Mínimo

$80.480

Volume

5.34M

Fundamentos da empresa

Capitalização de mercado

255.3B

Setor

Drug Manufacturers - General

País

United Kingdom

Estatísticas de negociação

Volume médio

4.52M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $61.24Atual $82.030Máximo $86.57

Notícias relacionadas

BusinessWire

DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer

The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line

Ver mais
DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer
CNBC

ServiceNow CEO denies AI companies are threatening enterprise software: 'They don't do what we do'

ServiceNow CEO Bill McDermott pushed back against the idea that artificial intelligence technology will make enterprise software redundant.

Ver mais
ServiceNow CEO denies AI companies are threatening enterprise software: 'They don't do what we do'
CNBC

Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound

Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.

Ver mais
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound